Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya

BACKGROUND: Pre-treatment HIV-drug-resistance (PDR) to WHO-recommended 1st-line non-nucleoside reverse transcriptase inhibitors (NNRTI)-based antiretroviral treatment (ART) is increasing in low-resource communities. We evaluated the risk of PDR on treatment failure if detected at single or multiple...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Ingrid A., Levine, Molly, McGrath, Christine J., Bii, Steve, Milne, Ross S., Kingoo, James M., So, Isaac, Andersen, Nina, Dross, Sandra, Coombs, Robert W., Kiarie, James, Chohan, Bhavna, Sakr, Samah R., Chung, Michael H., Frenkel, Lisa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962698/
https://www.ncbi.nlm.nih.gov/pubmed/31956856
http://dx.doi.org/10.1016/j.eclinm.2019.100239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962698/
https://www.ncbi.nlm.nih.gov/pubmed/31956856
http://dx.doi.org/10.1016/j.eclinm.2019.100239

Ejemplares similares